Difference between revisions of "Richard Hatchett"
Line 5: | Line 5: | ||
|death_date= | |death_date= | ||
|nationality=US | |nationality=US | ||
− | |alma mater=Vanderbilt University, Duke University | + | |alma mater=Vanderbilt University,Duke University |
− | |||
|interests=public-private partnerships, vaccines | |interests=public-private partnerships, vaccines | ||
|constitutes=Pharma lobbyist | |constitutes=Pharma lobbyist | ||
Line 13: | Line 12: | ||
|powerbase= | |powerbase= | ||
|employment={{job | |employment={{job | ||
− | |title=Coalition for Epidemic Preparedness Innovations | + | |title=Chief Executive Officer of the Coalition for Epidemic Preparedness Innovations |
|start=April 2017 | |start=April 2017 | ||
− | |end= | + | |end= |
}} | }} | ||
− | '''Richard J. Hatchett''', MD, is Chief Executive Officer of the [[Coalition for Epidemic Preparedness Innovations]] (CEPI), a partnership funded by NATO countries, big pharma, big foundations (like [[Bill and Melinda Gates Foundation]]) and civil organizations (the [[WHO]]) that will finance and co-ordinate the effort to rush thorough vaccines in less than a year against high priority public health threats from | + | }} |
− | + | '''Richard J. Hatchett''', MD, is Chief Executive Officer of the [[Coalition for Epidemic Preparedness Innovations]] (CEPI), a partnership funded by NATO countries, big pharma, big foundations (like [[Bill and Melinda Gates Foundation]]) and civil organizations (the [[WHO]]) that will finance and co-ordinate the effort to rush thorough vaccines in less than a year against high priority public health threats from pandemics or epidemics. | |
− | |||
+ | ==Background== | ||
A graduate of [[Vanderbilt University]] and the Vanderbilt University Medical School, he completed a residency in internal medicine at the New York Hospital – [[Cornell Medical Centre]] and a fellowship in medical oncology at [[Duke University]] Medical Centre. | A graduate of [[Vanderbilt University]] and the Vanderbilt University Medical School, he completed a residency in internal medicine at the New York Hospital – [[Cornell Medical Centre]] and a fellowship in medical oncology at [[Duke University]] Medical Centre. | ||
− | == | + | ==Career== |
+ | Prior to joining CEPI, Dr. Hatchett most recently served as acting Director of the [[U.S. Biomedical Advanced Research and Development Authority]] (BARDA), after serving for five years as BARDA’s Chief Medical Officer and Deputy Director. At BARDA, Dr. Hatchett oversaw programs to develop medical countermeasures against chemical, biological, radiological and nuclear threats, pandemic influenza, and emerging infectious diseases and led or helped lead the development of [[vaccines]], therapeutics, and diagnostics for a number of emerging viruses, including the H3N2v and H7N9 influenza viruses, [[MERS]], [[Ebola]] and [[Zika]]. <ref>https://www.lshtm.ac.uk/newsevents/events/richard-hatchett-lshtm</ref> | ||
− | + | Previously, Dr. Hatchett served on the [[White House Homeland Security Council]] under President [[George W. Bush]] and was a member of the White House National Security Staff under President [[Barack Obama]]. He is a recipient of the HHS Secretary’s Award for Distinguished Service and a five-time recipient of the NIH Director’s Merit Award. | |
− | |||
− | |||
==Covid-19== | ==Covid-19== | ||
− | + | In an April 2020 article, he reinforced several themes in the official narrative, the alleged unique danger from covid-19 (rather than the economic havoc from the lockdown measures); shilling for "large sums of money" to big pharma; and the alleged (and rather suspicious) need for everybody in the world, especially poor people, to take this rushed trough vaccine: | |
− | In an April 2020 article, he reinforced several themes in the official narrative, the alleged unique danger from covid-19 (rather than the economic havoc from the | ||
"This pandemic is the biggest public health threat that humankind has faced in a century". It is wreaking havoc on societies and economies and it is an acid test for [[public-private partnerships]]. We need to move fast to unleash the funding required to develop vaccines. Delivering covid-19 vaccines for the world—at record speed—will take a collective effort. We must combine the resources and expertise of academia and the private sector with the ability only governments have to mobilise the political will and amass the large sums of money that will be required....Given the threat posed by covid-19 we must regard vaccines as a global good: a shared resource that is deployed for the good of all irrespective of a country’s ability to pay."<ref>https://eiuperspectives.economist.com/healthcare/world-must-devise-globally-fair-covid-19-vaccine-allocation-system</ref> | "This pandemic is the biggest public health threat that humankind has faced in a century". It is wreaking havoc on societies and economies and it is an acid test for [[public-private partnerships]]. We need to move fast to unleash the funding required to develop vaccines. Delivering covid-19 vaccines for the world—at record speed—will take a collective effort. We must combine the resources and expertise of academia and the private sector with the ability only governments have to mobilise the political will and amass the large sums of money that will be required....Given the threat posed by covid-19 we must regard vaccines as a global good: a shared resource that is deployed for the good of all irrespective of a country’s ability to pay."<ref>https://eiuperspectives.economist.com/healthcare/world-must-devise-globally-fair-covid-19-vaccine-allocation-system</ref> | ||
+ | |||
+ | |||
{{SMWDocs}} | {{SMWDocs}} | ||
==References== | ==References== | ||
{{Reflist}} | {{Reflist}} |
Revision as of 19:00, 21 April 2020
Richard Hatchett (Pharma lobbyist) | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|
Nationality | US | |||||||||
Member of | Coalition for Epidemic Preparedness Innovations/Board, Covid Commission Planning Group | |||||||||
Interests | • public-private partnerships • vaccines | |||||||||
Homeland Security Medical Expert
|
Richard J. Hatchett, MD, is Chief Executive Officer of the Coalition for Epidemic Preparedness Innovations (CEPI), a partnership funded by NATO countries, big pharma, big foundations (like Bill and Melinda Gates Foundation) and civil organizations (the WHO) that will finance and co-ordinate the effort to rush thorough vaccines in less than a year against high priority public health threats from pandemics or epidemics.
Background
A graduate of Vanderbilt University and the Vanderbilt University Medical School, he completed a residency in internal medicine at the New York Hospital – Cornell Medical Centre and a fellowship in medical oncology at Duke University Medical Centre.
Career
Prior to joining CEPI, Dr. Hatchett most recently served as acting Director of the U.S. Biomedical Advanced Research and Development Authority (BARDA), after serving for five years as BARDA’s Chief Medical Officer and Deputy Director. At BARDA, Dr. Hatchett oversaw programs to develop medical countermeasures against chemical, biological, radiological and nuclear threats, pandemic influenza, and emerging infectious diseases and led or helped lead the development of vaccines, therapeutics, and diagnostics for a number of emerging viruses, including the H3N2v and H7N9 influenza viruses, MERS, Ebola and Zika. [1]
Previously, Dr. Hatchett served on the White House Homeland Security Council under President George W. Bush and was a member of the White House National Security Staff under President Barack Obama. He is a recipient of the HHS Secretary’s Award for Distinguished Service and a five-time recipient of the NIH Director’s Merit Award.
Covid-19
In an April 2020 article, he reinforced several themes in the official narrative, the alleged unique danger from covid-19 (rather than the economic havoc from the lockdown measures); shilling for "large sums of money" to big pharma; and the alleged (and rather suspicious) need for everybody in the world, especially poor people, to take this rushed trough vaccine:
"This pandemic is the biggest public health threat that humankind has faced in a century". It is wreaking havoc on societies and economies and it is an acid test for public-private partnerships. We need to move fast to unleash the funding required to develop vaccines. Delivering covid-19 vaccines for the world—at record speed—will take a collective effort. We must combine the resources and expertise of academia and the private sector with the ability only governments have to mobilise the political will and amass the large sums of money that will be required....Given the threat posed by covid-19 we must regard vaccines as a global good: a shared resource that is deployed for the good of all irrespective of a country’s ability to pay."[2]
Events Participated in
Event | Start | End | Location(s) | Description |
---|---|---|---|---|
Munich Security Conference/2020 | 14 February 2020 | 16 February 2020 | Germany Munich Bavaria | The 56th Munich Security Conference, in 2020, "welcomed an unprecedented number of high-ranking international decision-makers." |
Munich Security Conference/2022 | 18 February 2022 | 20 February 2022 | Germany Munich Bavaria | Slightly less than 1/3 of the 664 of the participants have pages here |
One Year Commemoration of the High-Level Meeting on UHC - Measuring Progress Challenges and Opportunities in the Context of COVID-19 | 8 October 2020 | 8 October 2020 | A number of ministers meeting online under the aegis of the WHO Director-General, musing on the challenges and opportunities for "building back better" | |
Preventing Global Catastrophic Biological Risks | 14 February 2020 | 16 February 2020 | Germany Munich Security Conference Munich | Simulation of a global influenza pandemic predicting an apocalyptic outcome. Held February 2020, with a who-is-who of pandemic planners. Held February 2020. |
WEF/Annual Meeting/2019 | 22 January 2019 | 25 January 2019 | World Economic Forum Switzerland | "The reality is that we are in a Cold War [against China] that threatens to turn into a hot one." |
WEF/Annual Meeting/2020 | 21 January 2020 | 24 January 2020 | World Economic Forum Switzerland | This mega-summit of the world's ruling class and their political and media appendages happens every year, but 2020 was special, as the continuous corporate media coverage of COVID-19 started more or less from one day to the next on 20/21 January 2020, coinciding with the start of the meeting. |
WEF/Annual Meeting/2022 | 22 May 2022 | 26 May 2022 | World Economic Forum Switzerland | 1912 guests in Davos |
WEF/Annual Meeting/2023 | 16 January 2023 | 20 January 2023 | World Economic Forum Switzerland | The theme of the meeting was "Cooperation in a Fragmented World" |